Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
SCOTUS offers another short-term extension for abortion pill's approval
3 years ago
Law
FDA's pain adcomm debates clinical trial designs for opioid post-marketing trials
3 years ago
R&D
Pharma
Legend raises $200M from private investor after conference leaks PhIII Carvykti data
3 years ago
Financing
Cell/Gene Tx
Ireland added to EMA/FDA joint generic inspection initiative
3 years ago
FDA+
Manufacturing
As Eli Lilly's Mounjaro prescriptions skyrocket, analyst predicts $50B in yearly tirzepatide sales
3 years ago
Pharma
Marketing
Trade union calls for walkouts at GSK manufacturing sites in the UK
3 years ago
People
Manufacturing
Four senior FDA leaders forged close ties with Biogen well ahead of Aduhelm's approval. Now they've left FDA
3 years ago
People
FDA+
Karyopharm stock drops after inhibitor's PhI data show lower dose not as effective: #AACR23
3 years ago
R&D
Gamida Cell looks to get $22M+ on its public offering launch; Esperion signs co-promotion pact with Currax
3 years ago
News Briefing
In a leaked abstract, J&J's cell therapy appears to have dramatic benefits for multiple myeloma patients
3 years ago
R&D
Pharma
Vaxcyte to raise $500M from stock offering for PhIII study of pneumococcal vaccine
3 years ago
Financing
Roche's Foundation Medicine lays off 135 workers
3 years ago
People
Gilde Healthcare bags $657M to fuel 'holistic' search for affordable drugs, technologies
3 years ago
Financing
KRAS, one of cancer’s toughest targets, sees a surge of new therapies trying to limit side effects: #AACR23
3 years ago
R&D
European biotech VC Forbion closes two funds at $1.5B total in its biggest raises to date
3 years ago
Financing
Majority of top-selling Medicare drugs offer little added benefit to alternatives, researchers find
3 years ago
Pharma
Law
AbbVie's Qulipta adds FDA approval for chronic migraine
3 years ago
Pharma
FDA simplifies Covid-19 bivalent vaccination process ahead of June adcomm
3 years ago
Pharma
FDA+
J&J sales near $25B for Q1, with solid oncology, immunology gains
3 years ago
Pharma
Palleon unveils PhI look at 'lawn mower' approach to glycoimmunology: #AACR23
3 years ago
People
R&D
Consumer trust in pharma industry holds steady amid economic, inequality uneasiness — Edelman survey
3 years ago
Pharma
Marketing
MarketingRx roundup: Eisai partners on head and neck cancer campaign; AstraZeneca, Daiichi ads pop up at AACR
3 years ago
Pharma
Marketing
Basilea pushes back FDA submission for antibiotic over CMO issues
3 years ago
R&D
Manufacturing
Otsuka subsidiary gets date with FDA for Lonsurf combo; Vaxcyte sells stock to bankroll PhIII vaccine trial
3 years ago
News Briefing
First page
Previous page
354
355
356
357
358
359
360
Next page
Last page